Region: India

Ericsson and Nokia v Oppo signal that non-discriminatory terms are key concern for Indian courts

Featured in SEP/FRAND Hub

Recent case law, along with the trend for out-of-court settlements between SEP holders and mobile manufacturers, highlights that the non-discriminatory part of ‘FRAND’ is being treated as a priority right now.

24 March 2023

Indian Patent Office and Delhi High Court at odds over lack of sufficient reasoning in landscape-shaping decisions

The Delhi High Court has had to raise natural justice principles with the Patent Office in multiple 2022 cases, a crucial reminder that parties must be provided with fair opportunities and rulings backed with reasonable explanations.

15 March 2023

Immersion sets sights on Xiaomi royalties, suing in Europe and India

The NPE seeks to grow income as use of haptics technology picks up

13 March 2023

Natural justice redefined and reinforced in key 2022 decisions against the Patent Office

Last year saw many decisions that could well have a lasting impact on the Indian prosecution landscape. The Delhi High Court continued to display its strength as it went head-to-head with the Indian Patent Office in several landmark rulings.

01 March 2023

Oppo rejects Nokia’s arbitration proposal

The Chinese handset maker has opted to fight on for now, but alludes to "counter-offer" in the pipeline.

27 February 2023

Critical 2022 high court decisions shaping the Indian prosecution landscape

The abolishment of the IPAB in 2021 sparked doubts about whether India’s high courts could handle the heavy case load. However, the Delhi High Court continues to prove its ability to stand strong as it rules on claim amendments and divisional applications.

22 February 2023

Indian patent office budget hike bodes well but spending is the real issue

A 15% boost could help bolster staffing and shorten timelines but smarter use of funds is essential

20 February 2023

Delhi High Court challenges Indian Patent Office’s refusal order in landmark pharma ruling

In a decision involving patent amendment claims in pharmaceutical applications, a high court has held that patent law is intended to foster innovation, research, technology and industrial progress and that the Indian Patent Office’s recent interpretation of Section 59 of the Patents Act directly opposes this view.

15 February 2023

Indian court hands hefty fine to generic drug boss who ignored Pfizer patent injunction

Triveni Interchem and its director deliberately flouted sales ban, rules Delhi judge

14 February 2023

Exclusive: Nokia makes arbitration offer to Oppo in bid to resolve 5G dispute

Proposal comes against background of discontent with conventional dispute resolution strategies

08 February 2023

Unlock unlimited access to all IAM content